| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Postural Tachycardia Syndrome | |||||
| Orthostatic Intolerance | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Mitral Valve Prolapse | |||||
| Neurocirculatory Asthenia | |||||
| Syndrome | |||||
| Tachycardia | |||||
| 3 | More general conditions related to this trial | ||||
| Anxiety Disorders | |||||
| Arrhythmias, Cardiac | |||||
| Cardiovascular Diseases | |||||
| Disease | |||||
| Heart Diseases | |||||
| Heart Valve Diseases | |||||
| Heart Valve Prolapse | |||||
| Mental Disorders | |||||
| Pathologic Processes | |||||
| 4 | Interventions listed in this trial | ||||
| Carbidopa | |||||
| Placebo | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Dopamine | |||||
| 6 | More general drug interventions related to this trial | ||||
| Autonomic Agents | |||||
| Cardiotonic Agents | |||||
| Cardiovascular Agents | |||||
| Dopamine Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Neurotransmitter Agents | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protective Agents | |||||
| Sympathomimetics | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Vanderbilt University | |||||
|
